|
1.
|
Weiser WY, Temple PA, Witek-Giannotti JS,
Remold HG, Clark SC and David JR: Molecular cloning of a cDNA
encoding a human macrophage migration inhibitory factor. Proc Natl
Acad Sci USA. 86:7522–7526. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Sugimoto H, Suzuki M, Nakagawa A, Tanaka I
and Nishihira J: Crystal structure of macrophage migration
inhibitory factor from human lymphocyte at 2.1 A resolution. FEBS
Lett. 389:145–148. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Sun HW, Bernhagen J, Bucala R and Lolis E:
Crystal structure at 2.6-A resolution of human macrophage migration
inhibitory factor. Proc Natl Acad Sci USA. 93:5191–5196. 1996.
View Article : Google Scholar
|
|
4.
|
Kato Y, Muto T, Tomura T, Tsumura H,
Watarai H, Mikayama T, Ishizaka K and Kuroki R: The crystal
structure of human glycosylation-inhibiting factor is a trimeric
barrel with three 6-stranded beta-sheets. Proc Natl Acad Sci USA.
93:3007–3010. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Nishino T, Bernhagen J, Shiiki H, Calandra
T, Dohi K and Bucala R: Localization of macrophage migration
inhibitory factor (MIF) to secretory granules within the
corticotrophic and thyrotrophic cells of the pituitary gland. Mol
Med. 1:781–788. 1995.PubMed/NCBI
|
|
6.
|
Flaster H, Bernhagen J, Calandra T and
Bucala R: The macrophage migration inhibitory factor-glucocorticoid
dyad: regulation of inflammation and immunity. Mol Endocrinol.
21:1267–1280. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Rossi AG, Haslett C, Hirani N, Greening
AP, Rahman I, Metz CN, Bucala R and Donnelly SC: Human circulating
eosinophils secrete macrophage migration inhibitory factor (MIF).
Potential role in asthma. J Clin Invest. 101:2869–2874. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
de Jong YP, Abadia-Molina AC, Satoskar AR,
Clarke K, Rietdijk ST, Faubion WA, Mizoguchi E, Metz CN, Alsahli M,
ten Hove T, Keates AC, Lubetsky JB, Farrell RJ, Michetti P, van
Deventer SJ, Lolis E, David JR, Bhan AK and Terhorst C: Development
of chronic colitis is dependent on the cytokine MIF. Nat Immunol.
2:1061–1066. 2001.PubMed/NCBI
|
|
9.
|
Morand EF, Leech M, Weedon H, Metz C,
Bucala R and Smith MD: Macrophage migration inhibitory factor in
rheumatoid arthritis: clinical correlations. Rheumatology (Oxford).
41:558–562. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Foote A, Briganti EM, Kipen Y, Santos L,
Leech M and Morand EF: Macrophage migration inhibitory factor in
systemic lupus erythematosus. J Rheumatol. 31:268–273.
2004.PubMed/NCBI
|
|
11.
|
Donn RP, Plant D, Jury F, Richards HL,
Worthington J, Ray DW and Griffiths CE: Macrophage migration
inhibitory factor gene polymorphism is associated with psoriasis. J
Invest Dermatol. 123:484–487. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Sanchez-Zamora Y, Terrazas LI,
Vilches-Flores A, Leal E, Juárez I, Whitacre C, Kithcart A, Pruitt
J, Sielecki T, Satoskar AR and Rodriguez-Sosa M: Macrophage
migration inhibitory factor is a therapeutic target in treatment of
non-insulin-dependent diabetes mellitus. FASEB J. 24:2583–2590.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Chesney J, Metz C, Bacher M, Peng T,
Meinhardt A and Bucala R: An essential role for macrophage
migration inhibitory factor (MIF) in angiogenesis and the growth of
a murine lymphoma. Mol Med. 5:181–191. 1999.PubMed/NCBI
|
|
14.
|
Zeng F-Y, Weiser WY, Kratzin H, Stahl B,
Karas M and Gabius HJ: The major binding protein of the interferon
antagonist sarcolectin in human placenta is a macrophage migration
inhibitory factor? Arch Biochem Biophys. 303:74–80. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Zeng FY, Gerke V and Gabius HJ:
Characterization of the macrophage migration inhibitory
factor-binding site of sarcolectin and its relationship to human
serum albumin. Biochem Biophys Res Commun. 200:89–94. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Kayser K, Bovin NV, Korchagina EY,
Zeilinger C, Zeng FY and Gabius H-J: Correlation of expression of
binding sites for synthetic blood group A-, B- and H-trisaccharides
and for sarcolectin with survival of patients with bronchial
carcinoma. Eur J Cancer. 30A:653–657. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Meyer-Siegler K and Hudson PB: Enhanced
expression of macrophage migration inhibitory factor in prostatic
adenocarcinoma metastases. Urology. 48:448–452. 1996. View Article : Google Scholar
|
|
18.
|
He XX, Yang J, Ding YW, Liu W, Shen QY and
Xia HH: Increased epithelial and serum expression of macrophage
migration inhibitory factor (MIF) in gastric cancer: potential role
of MIF in gastric carcinogenesis. Gut. 55:797–802. 2006. View Article : Google Scholar
|
|
19.
|
Hagemann T, Robinson SC, Thompson RG,
Charles K, Kulbe H and Balkwill FR: Ovarian cancer cell-derived
migration inhibitory factor enhances tumor growth, progression, and
angiogenesis. Mol Cell Ther. 6:1993–2002. 2007.PubMed/NCBI
|
|
20.
|
He XX, Chen K, Yang J, Li XY, Gan HY, Liu
CY, Coleman TR and Al-Abed Y: Macrophage migration inhibitory
factor promotes colorectal cancer. Mol Med. 15:1–10.
2009.PubMed/NCBI
|
|
21.
|
Krockenberger M, Engel JB, Kolb J,
Dombrowsky Y, Häusler SF, Kohrenhagen N, Dietl J, Wischhusen J and
Honig A: Macrophage migration inhibitory factor expression in
cervical cancer. J Cancer Res Clin Oncol. 136:651–657. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Kindt N, Lechien J, Decaestecker C,
Rodriguez A, Chantrain G, Remmelink M, Laurent G, Gabius H-J and
Saussez S: Expression of macrophage migration-inhibitory factor is
correlated with progression in oral cavity carcinomas. Anticancer
Res. 32:4499–4505. 2012.PubMed/NCBI
|
|
23.
|
Kindt N, Preillon J, Kaltner H, Gabius
H-J, Chevalier D, Rodriguez A, Johnson BD, Megalizzi V,
Decaestecker C, Laurent G and Saussez S: Macrophage migration
inhibitory factor in head and neck squamous cell carcinoma:
clinical and experimental studies. J Cancer Res Clin Oncol.
139:727–737. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Cludts S, Decaestecker C, Johnson B,
Lechien J, Leroy X, Kindt N, Kaltner H, André S, Gabius HJ and
Saussez S: Increased expression of macrophage migration inhibitory
factor during progression to hypopharyngeal squamous cell
carcinoma. Anticancer Res. 30:3313–3319. 2010.PubMed/NCBI
|
|
25.
|
Cournia Z, Leng L, Gandavadi S, Du X,
Bucala R and Jorgensen WL: Discovery of human macrophage migration
inhibitory factor (MIF)-CD74 antagonists via virtual screening. J
Med Chem. 52:416–424. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Winner M, Meier J, Zierow S, Rendon BE,
Crichlow GV, Riggs R, Bucala R, Leng L, Smith N, Lolis E, Trent JO
and Mitchell RA: A novel, macrophage migration inhibitory factor
suicide substrate inhibits motility and growth of lung cancer
cells. Cancer Res. 68:7253–7257. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Khurana D, Martin EA, Kasperbauer JL,
O’Malley BW Jr, Salomao DR, Chen L and Strome SE: Characterization
of a spontaneously arising murine squamous cell carcinoma (SCC VII)
as a prerequisite for head and neck cancer immunotherapy. Head
Neck. 23:899–906. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Journe F, Chaboteaux C, Dumon JC, Leclercq
G, Laurent G and Body JJ: Steroid-free medium discloses oestrogenic
effects of the bisphosphonate clodronate on breast cancer cells. Br
J Cancer. 91:1703–1710. 2004.PubMed/NCBI
|
|
29.
|
Baron N, Deuster O, Noelker C, Stüer C,
Strik H, Schaller C, Dodel R, Meyer B and Bacher M: Role of
macrophage migration inhibitory factor in primary glioblastoma
multiforme cells. J Neurosci Res. 89:711–717. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Al-Abed Y, Dabideen D, Aljabari B, Valster
A, Messmer D, Ochani M, Tanovic M, Ochani K, Bacher M, Nicoletti F,
Metz C, Pavlov VA, Miller EJ and Tracey KJ: ISO-1 binding to the
tautomerase active site of MIF inhibits its pro-inflammatory
activity and increases survival in severe sepsis. J Biol Chem.
280:36541–36544. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Meyer-Siegler KL, Iczkowski KA, Leng L,
Bucala R and Vera PL: Inhibition of macrophage migration inhibitory
factor or its receptor (CD74) attenuates growth and invasion of
DU-145 prostate cancer cells. J Immunol. 177:8730–8739. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
McClelland M, Zhao L, Carskadon S and
Arenberg D: Expression of CD74, the receptor for macrophage
migration inhibitory factor, in non-small cell lung cancer. Am J
Pathol. 174:638–646. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Merk M, Baugh J, Zierow S, Leng L, Pal U,
Lee SJ, Ebert AD, Mizue Y, Trent JO, Mitchell R, Nickel W, Kavathas
PB, Bernhagen J and Bucala R: The Golgi-associated protein p115
mediates the secretion of macrophage migration inhibitory factor. J
Immunol. 182:6896–6906. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Lue H, Kapurniotu A, Fingerle-Rowson G,
Roger T, Leng L, Thiele M, Calandra T, Bucala R and Bernhagen J:
Rapid and transient activation of the ERK MAPK signalling pathway
by macrophage migration inhibitory factor (MIF) and dependence on
JAB1/CSN5 and Src kinase activity. Cell Signal. 18:688–703. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Bifulco C, McDaniel K, Leng L and Bucala
R: Tumor growth-promoting properties of macrophage migration
inhibitory factor. Curr Pharm Des. 14:3790–3801. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Du W, Wright BM, Li X, Finke J, Rini BI,
Zhou M, He H, Lal P and Welford SM: Tumor-derived macrophage
migration inhibitory factor promotes an autocrine loop that
enhances renal cell carcinoma. Oncogene. 32:1469–1474. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Liu L, Ji C, Chen J, Li Y, Fu X, Xie Y, Gu
S and Mao Y: A global genomic view of MIF knockdown-mediated cell
cycle arrest. Cell Cycle. 7:1678–1692. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Rendon BE, Roger T, Teneng I, Zhao M,
Al-Abed Y, Calandra T and Mitchell RA: Regulation of human lung
adenocarcinoma cell migration and invasion by macrophage migration
inhibitory factor. J Biol Chem. 282:29910–29918. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Lee CY, Su MJ, Huang CY, Chen MY, Hsu HC,
Lin CY and Tang CH: Macrophage migration inhibitory factor
increases cell motility and up-regulates αvβ3 integrin in human
chondrosarcoma cells. J Cell Biochem. 113:1590–1598.
2012.PubMed/NCBI
|
